Filter Results
Related Organization
- Biological and Environmental Systems Science Directorate (23)
- Computing and Computational Sciences Directorate (35)
- Energy Science and Technology Directorate (217)
- Fusion and Fission Energy and Science Directorate (21)
- Information Technology Services Directorate (2)
- Isotope Science and Enrichment Directorate (6)
- National Security Sciences Directorate (17)
- Neutron Sciences Directorate (11)
- Physical Sciences Directorate (128)
- User Facilities (27)
Researcher
- Andrzej Nycz
- Chris Masuo
- Luke Meyer
- Mingyan Li
- Sam Hollifield
- William Carter
- Alex Walters
- Brian Weber
- Bruce Hannan
- Bruce Moyer
- Debjani Pal
- Isaac Sikkema
- Jeffrey Einkauf
- Jennifer M Pyles
- Joseph Olatt
- Joshua Vaughan
- Justin Griswold
- Kevin Spakes
- Kunal Mondal
- Kuntal De
- Laetitia H Delmau
- Lilian V Swann
- Loren L Funk
- Luke Koch
- Luke Sadergaski
- Mahim Mathur
- Mary A Adkisson
- Mike Zach
- Oscar Martinez
- Padhraic L Mulligan
- Peter Wang
- Polad Shikhaliev
- Sandra Davern
- Theodore Visscher
- T Oesch
- Vladislav N Sedov
- Yacouba Diawara

Ruthenium is recovered from used nuclear fuel in an oxidizing environment by depositing the volatile RuO4 species onto a polymeric substrate.

ORNL has developed a large area thermal neutron detector based on 6LiF/ZnS(Ag) scintillator coupled with wavelength shifting fibers. The detector uses resistive charge divider-based position encoding.

Spherical powders applied to nuclear targetry for isotope production will allow for enhanced heat transfer properties, tailored thermal conductivity and minimize time required for target fabrication and post processing.

Real-time tracking and monitoring of radioactive/nuclear materials during transportation is a critical need to ensure safety and security. Current technologies rely on simple tagging, using sensors attached to transport containers, but they have limitations.

Biocompatible nanoparticles have been developed that can trap and retain therapeutic radionuclides and their byproducts at the cancer site. This is important to maximize the therapeutic effect of this treatment and minimize associated side effects.